Meikle Phillip Terry II 4
4 · Bone Biologics Corp · Filed Oct 18, 2024
Insider Transaction Report
Form 4
Meikle Phillip Terry II
Director
Transactions
- Award
Non-Employee Stock Option
2024-10-16+9→ 9 totalExercise: $1.88Exp: 2034-10-16→ Common Stock (9 underlying) - Award
Non-Employee Stock Option
2024-10-16+28,185→ 28,185 totalExercise: $1.88Exp: 2034-10-16→ Common Stock (28,185 underlying)
Footnotes (2)
- [F1]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable on the date of the next annual meeting of the stockholders of the Company following the grant date.
- [F2]This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vesting and becoming exercisable in four equal installments on 12/17/24, 3/19/25, 6/19/25 and 9/17/25.